Former Manchester United and England star Wayne Rooney has invested in a Cheshire firm's new therapeutic product that enables medical professionals and physiotherapists to support injured athletes back to fitness faster.

Mr Rooney will also act as a brand ambassador for ProMOTION EV1 which delivers portable therapy and the ability to monitor progress outside of the physio room.

The product delivers targeted temperature and compression control with none of the reduction in muscle strength that can arise from global cryotherapy, Swellaway Ltd has said.

The Lymm-based company added that the product has received multi-million pound investment from the likes of Mr Rooney, as well as physios, surgeons and other football-focused medical professionals.

Swellaway has previously worked closely with elite clubs in football, rugby union, rugby league, as well as universities and academics such as Manchester Metropolitan and the University of Central Lancashire (UCLan).

Don't miss a thing - sign up for your free North West newsletter - and follow us on LinkedIn

BusinessLive North West

Email newsletters

BusinessLive is your home for business news from around the North West- and you can stay in touch with all the latest news from Greater Manchester, Liverpool City Region, Cheshire, Lancashire and Cumbria through our email alerts.

You can sign up to receive daily morning news bulletins from every region we cover and to weekly email bulletins covering key economic sectors from manufacturing to technology and enterprise. And we'll send out breaking news alerts for any stories we think you can't miss.

Visit our email preference centre to sign up to all the latest news from BusinessLive.

LinkedIn

For all the latest stories, views, polls and more - and the news as it breaks - follow our BusinessLive North West LinkedIn page here.

Mr Rooney said: "I have been involved with Swellaway as a founding investor for many years, as the team have continued to develop their technology.

"I have worked alongside many senior professors and medical practitioners in sports science and medicine to take part in the development and trials required to get the product to where it is today.

"During the course of my career, I could see how the introduction of technology was helping to advance elite level sport.

"It made absolute sense to me that such technological advancements could be used in the area of treatments for impact and musculoskeletal injuries which would be better served by a product led by science and technology rather than clingfilm and ice."